Latvijas Biomedicīnas Pētījumu Un Studiju Centrs Overview
- Year Founded
-
1993
- Status
-
Private
- Employees
-
86
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Latvijas Biomedicīnas Pētījumu Un Studiju Centrs General Information
Description
Provider of medical services intended for molecular and cell biology research. The company's services are engaged in both fundamental and translational research in various areas of biomedicine, which can give competent consultations as well as give technical support for various research activities on human genetics and disease mechanisms, cancer research, biotechnology, structural biology, enabling doctors to increase the quality of scientific research and promote scientific progress.
Contact Information
Website
www.biomed.lu.lv
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Commercial Services
Primary Office
- Rātsupītes iela 1 k-1
- Riga, LV-1067
- Latvia
+371 67 000 000
Latvijas Biomedicīnas Pētījumu Un Studiju Centrs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
Latvijas Biomedicīnas Pētījumu Un Studiju Centrs Patents
Latvijas Biomedicīnas Pētījumu Un Studiju Centrs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3135295-A1 | Coupling of borrelial protein bb0689 to virus-like particles for generation of lyme disease vaccine | Inactive | 28-Aug-2015 | 00000000000 | 0 |
| EP-3135686-A1 | Novel recombinant cyclized human growth hormone | Inactive | 28-Aug-2015 | 000000000 | 0 |
| EP-3135770-A1 | Set of oligonucleotides and method for detection of fetal dna fraction in maternal plasma | Inactive | 28-Aug-2015 | 0000000000 | 0 |
| EP-2875815-A1 | N'-(2-(3-oxobenzo[d]isothiazol-2(3h)-yl)acetyl)adamantane-1-carbohydrazide as a novel inhibitor for staphylococcus aureus sortase a | Inactive | 21-Nov-2013 | 0000000000 | 0 |
| EP-2875816-A1 | N-(3-hydroxy-5,7-dimethyladamantan-1-yl)-2-(3-oxobenzo[d]isothiazol-2(3h)-yl)acetamide as a novel inhibitor for staphylococcus aureus sortase a | Inactive | 21-Nov-2013 | A61K31/428 | 0 |
Latvijas Biomedicīnas Pētījumu Un Studiju Centrs Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Janis Klovins | Head of the Scientific Council |
Latvijas Biomedicīnas Pētījumu Un Studiju Centrs Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Latvijas Biomedicīnas Pētījumu Un Studiju Centrs Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Accelerace | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |